Mental Health DailyResearch. Evidence. Perspective.Published research on treatment resistant depression.
Lanicemine (AZD6765) is an NMDA antagonist developed by the company AstraZeneca in hopes to help people with treatment-resistant depression. Let’s face it, if you have treatment-resistant de…
Read articleLithium carbonate has become a very popular augmentation option for treatment-resistant depression. If you have treatment resistant depression, chances are that most psychiatrists have explo…
Read articleThe use of stimulants like Adderall for cases of treatment-resistant depression is not very common these days. It is much more common for a psychiatrist to put the patient through the ringer…
Read article